研究業績

研究業績
論文等

実験動物学
Effects of transmaternal exposure to genistein in Hatano high- and low-avoidance rats
Ryo OHTA, Mariko SHIROTA, Yukiko KANAZAWA, Tomoko SHINDO, Mami FURUYA, Takayuki SEKI,
Hiroshi ONO, Kohichi KOJIMA, Sayaka ASAI1, Gen WATANABE1, Kazuyoshi TAYA1
Experimental Animals, 2009; 58(5): 471-479
Hatano high- and low-avoidance (HAA and LAA) rats are separated by breeding from SpragueDawley rats by high versus low rates of avoidance responses in a shuttle-box task. In addition,compared to HAA rats, LAA rats show lower running-wheel activity, later sexual maturation,
5-day estrous cycling, lower sperm motility, more pronounced immunological reactions, andare generally less reactive to stress. The present study was designed to compare the effects oftransmaternal exposure to genistein on these characteristics between HAA and LAA rats. To
this aim, litters from both strains were fostered onto Sprague-Dawley rats receiving genistein
by gavage with 5 mg/animal/day from day 17 of pregnancy through day 21 of lactation. Inhibited
growth after weaning and reduced uterine weight at weaning were observed in the LAA offspring
reared by genistein-treated dams. IgM antibody production in response to sheep red blood cells was
significantly decreased in the HAA offspring reared by genistein-treated dams. During restraint
stress, the plasma concentration of corticosterone was significantly lower in the LAA offspring
reared by genistein-treated dams. Strain-related differences were detected in shuttle-box avoidance
performance, running-wheel activity, estrous cycling, and sperm motility. The results demonstratethat transmaternal exposure to genistein potentially affects the immunological and stress responses
as well as the post-weaning growth of the offspring. It suggests that a comparative study using
Hatano rats would be useful for studying the inﬂuence of endocrine active chemicals on the wholebody systems.
1

Faculty of Agriculture, Tokyo University of Agriculture and Technology

技術指導員の活動と役割
畔上二郎
LABIO21, 2010; 39: 10-11

毒性病理学
Early embryonic losses in mice induced by diethylstilbestrol
Tetsuji NAGAO1, Shinsuke YOSHIMURA
Congenital Anomalies, 2009; 49(4): 269-273
Estrogens cause embryonic lethality and the disturbance of early placental development inmice. Diethylstilbestrol (DES) at 1, 10, or 100 µg/kg was orally administered to Institute of Cancer
Research mice on gestational days (GD) 4 through 8, and the uterus and placenta were examined59

秦野研究所年報 Vol. 33. 2010

histopathologically on GD 9. Decidua of DES-treated mice showed insufficient development, and theuterine lumen at the implantation site did not effectively minimize. The trophoblast giant cell layer
was not separated from the uterine lumen by the decidua capsularis, and hemorrhage from thedenuded trophoblast giant cell layer into the uterine lumen was noted at the peripheral part of thedecidua basalis. The results of the present study suggest that decidual hypoplasia and subsequent
placental hemorrhage causes fetal death due to the administration of DES during the early stage ofpregnancy.
1

Department of Life Science, Kinki University

一般毒性学
Safety assessment of Lactobacillus brevis KB290 as a probiotic strain
Takafumi YAKABE1, Emma L. MOORE2, Shunji YOKOTA, Hajime SUI, Yukihiro NOBUTA1, Masanori
FUKAO1, Helen A. PALMER2, Nobuhiro YAJIMA1
Food and Chemical Toxicology, 2009; 47(10): 2450-2453
Lactobacillus brevis KB290 (KB290), a plant-derived probiotic lactic acid bacterium, reportedly
improves gut health and stimulates immune function. Here we extensively investigated the geno-,
acute, subacute, and subchronic toxicity of KB290 and its bacterial translocation potential. KB290
was non-mutagenic in the bacterial reverse mutation assay by the preincubation method. In the
single oral dose toxicity test, KB290 at ≥ 109 cfu/mL was nontoxic at maximum capacity (20 mL/kg).
When 108, 109, or 1010 cfu/kg was administered daily to rats by gavage for 2 weeks (subacute assay),we observed no clear treatment-related effect and no evidence of bacterial translocation from thegastrointestinal tract. When it was administered for 13 weeks (subchronic assay), we again observed
no clear treatment-related effect and no significant toxicological effect. Based on those results,
we consider 10 10 cfu/kg per day, the highest dose tested, to be the no observed adverse effect level(NOAEL). These results suggest that KB290 is safe for human consumption.
1

Research Institute, Kagome Co., Ltd.; 2Huntingdon Research Centre, Huntingdon Life Sciences Ltd.

Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase
Alan R. PARRISH1, Gang CHEN1, Robert C. BURGHARDT2, Takaho WATANABE, Christophe MORISSEAU3,
Bruce D. HAMMOCK3
Cell Biology and Toxicology, 2009; 25(3): 217-225
Cisplatin is a highly effective chemotherapeutic agent against many tumors; however, it is also a
potent nephrotoxicant. Given that there have been no significant advances in our ability to clinicallymanage acute renal failure since the advent of dialysis, the development of novel strategies to ablate
nephrotoxicity would represent a significant development. In this study, we investigated the ability of an
inhibitor of soluble epoxide hydrolase (sEH), n-butyl ester of 12-(3-adamantan-1-yl-ureiido)-dodecanoic
acid (nbAUDA), to attenuate cisplatin-induced nephrotoxicity. nbAUDA is quickly converted to AUDA
and results in maintenance of high AUDA levels in vivo. Subcutaneous administration of 40 mg/kg
of nbAUDA to C3H mice every 24 h resulted in elevated blood levels of AUDA; this protocol was also
associated with attenuation of nephrotoxicity induced by cisplatin (intraperitoneal injection) as assessed
by BUN levels and histological evaluation of kidneys. This is the first report of the use of sEH inhibitors
to protect against acute nephrotoxicity and suggests a therapeutic potential of these compounds.
1

60

Department of Systems Biology and Translational Medicine, College of Medicine, Texas A&M

研究業績

Health Science Center; 2Department of Veterinary Integrated Biosciences, College of Veterinary
Medicine, Texas A&M University; 3Department of Entomology and UCD Cancer Center,
University of California at Davis

細胞毒性学
Comparison of sensitivity to arsenic compounds between a Bhas 42 cell transformation
assay and a BALB/c 3T3 cell transformation assay
Dai MURAMATSU, Kiyoshi SASAKI, Sachiko KURODA, Kumiko HAYASHI, Noriho TANAKA, Ayako SAKAI
Mutation Research, 2009; 675(1-2): 66-70
A short-term cell transformation assay has recently been developed, using Bhas 42 cells whichwere established from BALB/c 3T3 cells transfected by v-Ha-ras gene and postulated to be initiatedin the two-stage carcinogenesis theory. The Bhas 42 cell transformation assay has been reported
to be capable of detecting initiating and promoting activities of chemical carcinogens, according to
the different protocols, initiation assay and promotion assay, respectively. The assay is superior toclassical transformation assays in cost and labor performance. The present study was carried out
to compare its sensitivity with that of a classical BALB/c 3T3 cell system. We performed the Bhas
42 cell transformation assay with inorganic arsenic compounds which are potent environmental
carcinogens in human but not mutagens in bacteria or weak mutagens in mammalian cells in
vitro. Sodium arsenite, disodium arsenate, and their metabolites, monomethylarsonic acid anddimethylarsinic acid (DMAA) were included in the study. Sodium arsenite was positive in theinitiation assay and all compounds except for DMAA were positive in the promotion assay. These
results were compared with reported data in a two-stage BALB/c 3T3 cell transformation assay. The
sensitivity of Bhas 42 cell transformation assay was found to be similar to that of the conventional
BALB/c 3T3 cell transformation assay for the detection of initiating activities of arsenic compounds.
For the detection of promoting activities, its sensitivity was equivalent to that of the two-stage
BALB/c 3T3 cell transformation assay where the target cells were initiated with sub-thresholddose of 3-methylcholanthrene, confirming that Bhas 42 cells behave as initiated cells in thetransformation assay.

遺伝毒性学
Improvement and evaluation of High Throughput Fluctuation Ames Test using 384-wellplate with Salmonella typhimurium TA100 and TA98
Hajime SUI, Kumiko KAWAKAMI, Noriko SAKURAI, Takumi HARA, Takehiko NOHMI1
Genes and Environment, 2009; 31(2): 47-55
Recently, it has become necessary to increase the progress of research studies into drug discovery
because of the introduction of combinatorial chemistry and robotics. Therefore, genotoxicity
screening assays which can be conducted with a small amount of compound, in a short time, andwhich can predict the results of regulatory genotoxicity tests for pharmaceuticals are required in theearly stage of research. The bacterial reverse mutation test (Ames test) is a regulatory genotoxicity
test and is conducted in the early stage of non-clinical safety studies. Morita established a highthroughput ﬂuctuation Ames test using 384-well plates with Salmonella typhimurium TA100 and
TA98 (Environ. Mutagen Res. 2003, 25: 23-31), which is referred to as original FAT in the present
study. Here, we report an improved high throughput fluctuation Ames test (improved FAT). The
61

秦野研究所年報 Vol. 33. 2010

improved FAT indicated a higher positive response than the original FAT in several mutagens.
Furthermore, we evaluated the improved FAT with TA100 and TA98 using 40 National Toxicology
Program (NTP) chemicals. As a result, there was 80.0% (32/40) concordance between the Ames
test and the improved FAT. In conclusion, the improved FAT can predict the results of the Ames
test with high concordance (especially its negative specificity). The improved FAT requires amuch smaller amount of test chemicals than the Ames test (i.e., 5 mg vs 100 mg when using two
tester strains) and is able to be automated. Thus, the improved FAT is considered to be useful as ascreening test in the early stage of drug discovery.
1

National Institute of Health Sciences

Practical issues on the application of the GHS classification criteria for germ cellmutagens
Takeshi MORITA1, Makoto HAYASHI2, Madoka NAKAJIMA2, Noriho TANAKA, David J. TWEATS3, Kaoru
MORIKAWA1, Toshio SOFUNI4
Regulatory Toxicology and Pharmacology, 2009; 55(1): 52-68
The Globally Harmonized System of Classification and Labeling of Chemicals (GHS) requires
classification of chemicals on germ cell mutagenicity. The Japanese government has conducted
GHS classification on about 1400 chemicals in a 2-year project (J-GHS) for implementing GHS
domestically. Prior to the classification work, the technical guidance for classification of germ
cell mutagens was prepared. This guidance introduces the concept of heritable mutagenicity, andpresents detailed criteria for germ cell mutagens, test data to be used, and a practical decision tree
for classification. These practical guidance and supporting explanations are useful for non-expert
Classifiers (scientists applying the classification criteria). Several issues, however, were identified
during the course of J-GHS and in re-evaluating the classification results. These include: (1) the
information sources when available data are limited; (2) lack of understanding GHS classification
criteria or insufficient review of the information by Classifiers; (3) varying opinions of experts ondata quality and weight of evidence, and; (4) decision tree approaches, e.g., inadequacy for use in
overall evaluation in some cases. Ideally, classification should be performed by Classifiers with highexpertise using high quality information sources. Genetic toxicologists as experts should consider
data quality and reliability, and give a critical review of all available information for support ofclassification. A weight of evidence approach is also required to assess mutagenic potential ofchemicals. Critical points for suitable classification for GHS are discussed.
1

National Institute of Health Sciences; 2Biosafety Research Center, Foods, Drugs and Pesticides;

3

The School of Medicine, University of Swansea; 4Formerly National Institute of Health Sciences

食品衛生学
Basic research on developing scallop tissue reference material for quality assurance of
diarrhetic shellfish poisoning (DSP) mouse bioassay. ―Stability of okadaic acid (OA)―
Masaru KAWASAKI, Yoshinori ITOH1, Shigeki YAMAMOTO1, Kenji MACHII1
Journal of Environmental Chemistry, 2010; 20(1): 1-8
The preparation of the reference material (RM) for mouse bioassay (MBA) of diarrheic shellfish
poisoning (DSP) toxin was attempted. To obtain basic data on the RM, the stability of okadaicacid (OA), which causes DSP, and the method of spiking scallop tissue with OA were examined.
62

研究業績

Microwave, ultrasonic wave, and UV, which are conventionally used in experiments or may exist inenvironment, did not affect on the recovery of OA. The recovery rate of OA from thermo treatment at
50-200°C was examined periodically. Results suggest that temperature has no effect on the recovery
rate of OA at temperatures used during conventional analysis and transportation. However, a rapid
decrease in recovery was observed during heating at more than 120°C. In addition, the half-life of
OA heated in the range of 120-130°C was 1 h. OA in acetone solution that was stored in brown vials
or dried at the bottom of brown vials was stable during freezing (-35°C), refrigeration, and storage
at room temperature (20°C) for six months. The titer of OA tested by MBA was stable in stocked
samples, but the recovery rate of OA decreased by about 10% at the HPLC level after 15 months ofstorage. It was clarified that the recovery rate of OA absorbed in filter paper decreased gradually
but the recovery rate of OA was stable under conditions of three-week refrigeration. Samples were
distributed to collaborating laboratories and their results of MBA were compared and we did not
find any problems on the quality of RM or on the results of MBA quality assurance.
1

National Institute of Health Sciences

動物実験代替法An interlaboratory collaborative study on a cell transformation assay using Bhas 42 cells
Noriho TANAKA, Kiyoshi SASAKI, Kumiko HAYASHI, Ayako SAKAI, Shin ASADA, Dai MURAMATSU,
Sachiko KURODA, Fukutaro MIZUHASHI1, Miho NAGAI1, Hiroshi SUZUKI2, Tadashi IMAMURA2, Masumi
ASAKURA3, Hidetaka SATOH4, Akiko SAKAMOTO4, Ryosuke NAKAO4, Hideki HIROSE5, Nana ISHII5,
Makoto UMEDA
Alternatives to Animal Testing and Experimentation, 2009; 14(1): 831-848
A sensitive cell transformation assay for tumor initiators as well as promoters has been developed
using a v-Ha-ras-transfected BALB/c 3T3 cell line, Bhas 42. In order to establish the method as aroutine procedure, we have conducted a NEDO Project for the confirmation of its usefulness. Six
laboratories joined in this project and examined nine chemicals, so as to be tested for a chemical by
three laboratories. Judgments on carcinogenic compounds, N-methyl-N’-nitro-N- nitrosoguanidine
and benzo[a]pyrene, were positive in the initiation assay and negative in the promotion assay.
Although benz[a]anthracene is a carcinogen and pyrene is reported to be non-carcinogenic toanimals, they gave positive results in both initiation and promotion assays. Anthracene, a noncarcinogen, was negative in both initiation and promotion assays. Mezerein, lithocholic acidand methapyrilene hydrochloride, known to act as tumor promoters, were judged positive inthe promotion assay and negative in the initiation assay. Phorbol, a negative control for tumorpromoting phorbol esters, was shown negative in both initiation and promotion assays. In conclusion,
this inter-laboratory collaborative study demonstrated that the Bhas 42 cell transformation assay isreproducible and applicable to the detection of both initiators and promoters, leaving the possibilityof more improvement by the modification of the protocol and guidance for the procedure.
1

Biosafety Research Center, Foods, Drugs and Pesticides; 2Ina Research Inc.; 3Japan Bioassay

Research Center; 4Japan Food Research Laboratories; 5Mitsubishi Chemical Safety Institute Ltd.

63

秦野研究所年報 Vol. 33. 2010

医療機器
医用材料の生物学的安全性評価
小島幸一
材料の科学と工学, 2009; 46(6): 261-266
医用材料や医療機器を世の中に提供するためには安全性が担保されている必要がある．そのひとつとして生物学的安全性の評価も必須である．国内で必要な生物学的安全性の評価試験について解説すると
ともに，国際的なガイドラインとの相違を概説した．生物学的安全性評価の必要性を意識して新規素材や医療機器の開発にあたることが求められる．

薬理学
Locally applied TCP inhibits tumor growth via possible activation of macrophages
Yukiko NAITO, Tomoko NAGATA, Shigehiro TACHIBANA, Mari OKIMOTO, Naoki OHARA, Yasuharu
HAKAMATSUKA1, Jinyan CHENG1Journal of Biomedical Materials Research Part A, 2010; 92(2): 542-547
The aim of this study was to investigate whether beta-tricalcium phosphate (TCP) inhibits cancer
growth, because TCP, a widely used bone replacement material, is known to attract immune cells.
Human colon cancer (WiDr) cells were subcutaneously injected on the backs of nude mice, andtumor growth was observed. Seven days after the injection, five animals were implanted with TCP
at the tumor sites, five animals were treated by a direct application of 0.12 mg cisplatin at thesites, and four animals were not treated, as a control. Tumor size on the 43rd day of implantation
was 1173 mm 3 in the TCP group and was smaller than that in the control, 1621 mm3. This
inhibition was comparable to that with cisplatin. Furthermore, tumor-growing rate in the TCP
group was significantly lower than that in the control group. Histopathological examination of thetumors showed migration of macrophages only in the TCP group, with TCP particles remaining
at the implantation loci. There were no between-group differences in neutrophil infiltration andangiogenesis. In another series of in vitro experiments, a concentration-dependent increase inluminol chemiluminescence was observed in isolated human peripheral neutrophils incubated with
TCP, and the chemiluminescence due to phagocytosis of opsonized zymosan in the presence of TCP
occurred with a lower level of TCP than when the chemiluminescence was due to TCP alone. These
results suggest that subcutaneously implanted TCP inhibits tumor growth of implanted WiDr cells,
and that the activation by TCP of macrophages plays a role in that inhibition.
1

Medical new Business Project, Corporate R&D Center, Olympus Corporation

発生神経毒性学
Observation of fetal brain in a rat valproate-induced autism model: a developmental
neurotoxicity study
Makiko KUWAGATA, Tetsuo OGAWA1,2, Seiji SHIODA1, Tomoko NAGATAInternational Journal of Developmental Neuroscience, 2009; 27(4): 399-405
Prenatal exposure to chemicals is well known to induce developmental abnormalities in thecentral nervous system of children. Developmental neurotoxicity (DNT) tests are important to
identify neurotoxic agents and prevent neurodevelopmental disorders. We have investigated
DNT, focusing on the fetal brain shortly after chemical exposure. To demonstrate a usefulness ofa study focusing on the fetal brain in DNT tests, we assessed the fetal brain in a rat valproate64

研究業績

induced autism model. Rats were treated with sodium valproate (VPA, 800 mg/kg) orally ongestational day (GD) 9 or 11 (VPA9 or VPA11), and the fetal brains were examined on GD16 using
immunohistochemistry for serotonin (5-HT), tyrosine hydroxylase (TH), and TuJ1 (neuron specificclass III β -tubulin). Hypoplasia of the cortical plate was induced in both VPA9 and VPA11 groups.
Abnormal migration of TH-positive and 5-HT neurons, possibly due to the appearance of an abnormallyrunning nerve tract in the pons, was observed only in the VPA11 group. In addition, when we compared
the incidence of these abnormalities between pregnant rats mated in our own animal facility (in-housegroup), and rats purchased pregnant (supplier group), the supplier group was much more sensitive,
especially to the pons abnormality. Shipping stress may affect the reproducibility of VPA-induced DNT.
The present results demonstrate that examination of the GD16 fetal brain was useful for detecting andcharacterizing abnormal development of the brain after VPA exposure. Further discussion was madewith reference to the findings in children with autism.
1

Department of Anatomy I, Showa University, School of Medicine; 2Anti-aging Medicine Funded

Research Labs, Showa University, School of Medicine
Biphasic effects of neonatal allopregnanolone on striatal dopamine metabolism
Katsumasa MUNEOKA1,2, Makiko KUWAGATA, Yukihiko SHIRAYAMA2,3, Tetsuo OGAWA1, Seiji SHIODA1
NeuroReport, 2009; 20(9): 860-863
Neurosteroids are known to modulate the development of the mesocorticolimbic system. We
examined the effects of low (1 mg/kg) and high (10 mg/kg) doses of allopregnanolone on monoamine
metabolism during the neonatal period (postnatal days 3-7) in rats. At 10 weeks of age, increases
in homovanillic acid/dopamine (DA) ratios were found in the striatum in both allopregnanolonetreated groups compared with control rats. However, striatal DA levels decreased only in the
low-allopregnanolone group and striatal homovanillic acid levels increased only in the highallopregnanolone group. Allopregnanolone did not significantly affect cortical DA metabolism, or
cortical or striatal serotonin metabolism. Data indicate that neonatal allopregnanolone treatment
has a biphasic effect on striatal DA metabolism.
1

Department of Anatomy I, Showa University, School of Medicine; 2Department of Psychiatry,

Chiba University Graduate School of Medicine; 3Department of Psychiatry, Teikyo University
Chiba Medical Center

内分泌学
Prolactin induces phosphorylation of the STAT5 in adrenal glands of Hatano rats during stress
Sukanya JAROENPORN1,2,3, Kentaro NAGAOKA4, Ryo OHTA, Gen WATANABE1,2, Kazuyoshi TAYA1,2
Life Sciences, 2009; 85(3-4): 172-177
Aims: To investigate the signaling of prolactin (PRL) in the adrenal gland during stress in Hatano
high- (HAA) and low-avoidance (LAA) rats.
Main methods: Adrenal glands of both strains were collected at 0, 15 and 30 min after stress. The
protein levels of phosphorylated STAT5 and the mRNA levels of melanocortin receptor 2 (MC2R)
and PRL receptor (PRLR) were analyzed. Furthermore, the effects of bromocriptine-induced
hypoprolactinemia on adrenocortical responses to stress were investigated.
Key findings: Adrenocorticotropic hormone (ACTH) concentrations in HAA were greater than
LAA, while the difference in PRL concentrations were found only at 120 min after stress induction.
65

秦野研究所年報 Vol. 33. 2010

No strain differences were observed in corticosterone or progesterone in response to stress. The
stress-induced increase in MC2R mRNA expression was higher in HAA, but there was a lowered
PRLR mRNA expression. STAT5 become highly phosphorylated in response to stress in both strains,
but bromocriptine led to a reduction the STAT5 phosphorylation. Exposure to bromocriptine wasassociated with a reduction in plasma PRL in response to stress in both strains, while the ACTH
levels were not altered. However, the decrease in corticosterone and progesterone in response tostress was observed only in bromocriptine-treated LAA rats.
Significans: These data show that PRL plays an important role in the regulation of corticosterone
and progesterone release in LAA but not in HAA during stress. These results suggest that PRL
increase in response to stress, and it acts on the adrenal cortex and thereby plays an important
physiologic role in protecting against acute stress.
1

Department of Basic Veterinary Science, The United School of Veterinary Sciences, Gifu

University; 2Laboratory of Veterinary Physiology, Department of Veterinary Medicine, Facultyof Agriculture, Tokyo University of Agriculture and Technology; 3Primate Research Unit,
Department of Biology, Faculty of Science, Chulalongkorn University; 4Laboratory of Animal
Breeding and Reproduction, The University of Tokyo
Differences in adrenocortical secretory and gene expression responses to stimulation invitro by ACTH or prolactin between high- and low-avoidance Hatano rats
Sukanya J AROENPORN 1,2, Kentaro N AGAOKA 3, Ryo O HTA , Mariko S HIROTA , Gen W ATANABE 1,2,
Kazuyoshi TAYA1,2
Stress, 2009; 12(1): 22-29
Rats of the Hatano high-avoidance (HAA) and low-avoidance (LAA) strains have been geneticallyselected on the basis of their two-way active avoidance behavior, and have different endocrine
responses to stress. The present study focused on the adrenal steroid hormone responses of the
Hatano strains and identifies differences in regulation of the adrenal cortex in vitro of HAA andLAA rats. Although incubation with prolactin (PRL) and/or adrenocorticotrophic hormone (ACTH)
resulted in a dose-dependent increase of corticosterone and progesterone release by adrenal cells
from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from
LAA rats as compared with HAA rats. This finding suggested that adrenal glands of HAA rats areless sensitive to PRL and/or ACTH than adrenals from LAA rats. Several possible intra-adrenal
regulators were investigated. The basal levels of expression of steroidogenic acute regulatory
protein (StAR) and the long form of the PRL receptor (PRLR-L) mRNAs were higher in adrenalsof LAA rats. ACTH treatment of adrenal cells from HAA rats resulted in statistically significant
increases in melanocortin receptor 2 (MC2R) mRNA expression, while neither ACTH nor PRL
altered MC2R mRNA expression in adrenal cells of LAA rats. Conversely, the increase in PRLR-L
mRNA expression induced by PRL was observed only in adrenal cells from LAA rats. Treatment ofadrenal cells with PRL and/or ACTH increased the expression of StAR and CYP11A1 mRNAs forboth Hatano strains. However, the induction of StAR mRNA expression was higher in LAA rats, but
the CYP11A1 response was lower. These findings indicate that adrenal cells of the LAA strain havehigher sensitivity to secretagogues than those of the HAA strain. These results suggest that PRL
may also be important in stimulating secretion of adrenal steroid hormones.
1

66

Department of Basic Veterinary Science, The United School of Veterinary Sciences, Gifu

研究業績

University; 2Laboratory of Veterinary Physiology, Faculty of Agriculture, Department of
Veterinary Medicine, Tokyo University of Agriculture and Technology; 3Laboratory of Animal
Breeding and Reproduction, The University of Tokyo
学会発表等

化学・生化学
Analytical technique and quality control for food safety
Takaho WATANABE
Pittcon 2010 Symposium Japan Symposium 2010 "Analytical Technology that supports Safety andSecurity in Future"

2010.2.28～3.5（Orlando, USA）

同会Abstract, pp. 25-28

免疫毒性学
経口感作および経口惹起によるマウスの食物アレルギーモデル (7)新藤智子, 香取輝美, 金澤由基子, 大沢基保, 小島幸一, 手島玲子1
第16回日本免疫毒性学会学術大会

2009.8.27～8.28（旭川）

同会講演要旨集, p. 71
1

国立医薬品食品衛生研究所

食物アレルゲン性のin vitro評価系の開発
香取輝美, 新藤智子, 金澤由基子, 大沢基保, 小島幸一, 手島玲子1
第16回日本免疫毒性学会学術大会

2009.8.27～8.28（旭川）

同会講演要旨集, p. 58
1

国立医薬品食品衛生研究所

実験動物学
BrlHan:WIST@Jcl(GALAS)由来甲状腺腫大ラットの遺伝性矮小児における，レボチロキシンナトリウム製剤投与効果
高島宏昌, 吉田由香, 瀬沼美華, 桑形麻樹子, 井上雪乃, 佐藤
第56回日本実験動物学会総会

旭1, 太田亮, 小島幸一, 青山博昭1

2009.5.14～5.16（さいたま）

同会講演要旨集, p. 184
1

財団法人残留農薬研究所

実験動物の死後直腸温，死後硬直，死後剖検所見の推移について
堀内伸二, 藤原広和
東京実験動物研究会

2009.6.19（東京）

有効な試験にするための動物実験手技
畔上二郎
第43回日本実験動物技術者協会

2009.10.9～10.10（新潟）

同会講演要旨集, p. 70
67

秦野研究所年報 Vol. 33. 2010

一般毒性学
4-エチルモルホリンおよび2-(ジ-n-ブチルアミノ)エタノールのラットにおける腎病変の比較―アクアポリンの免疫組織学的局在
森村智美, 熊谷文明, 古谷真美, 加藤博康, 臼見憲司, 斉藤義明
第36回日本トキシコロジー学会学術年会

2009.7.6～7.8（盛岡）Journal of Toxicological Sciences, 2009; 34(Suppl.): S118
SDラットにおける経口光毒性試験法の検討―5種の光毒性物質の比較―
田面喜之, 森村智美, 青木聡子, 須井哉, 川上久美子, 豊泉友康, 関

第36回日本トキシコロジー学会学術年会

剛幸, 太田亮, 小島幸一

2009.7.6～7.8（盛岡）Journal of Toxicological Sciences, 2009; 34(Suppl.): S189

生殖・発生毒性学
ラット母動物へのペントバルビタール投与による胎児の麻酔状態に関する検討
瀬沼美華, 高島宏昌, 吉田由香, 三枝克彦, 太田
第36回日本トキシコロジー学会学術年会

亮, 小島幸一

2009.7.6～7.8（盛岡）Journal of Toxicological Sciences, 2009; 34(Suppl.): S124
Effects of cell recovery factor in cell differentiation culture with the embryonic stem cell test
Koichi IMAI1, Shoji TAKEDA1, Shinji KUSAKAWA2, Akito TANOUE2, Makiko KUWAGATA, Mika SENUMA,
Mami FURUYA, Hiromasa TAKASHIMA
7th World Congress on Alternatives & Animal Use in the Life Sciences 2009.8.30～9.3（Rome, Italy）
Alternative to Animal Experimentation, 2009; 26, Special Issue: 116
1

Department of Biomaterials, Osaka Dental University; 2Department of Pharmacology, National

Research Institute for Child Health and Development
An attempt to include the human metabolic factor in to the embryotoxicity test by mouse EsD3 cells
Koichi IMAI1, Shoji TAKEDA1, Shinji KUSAKAWA2, Akito TANOUE2, Makiko KUWAGATA, Mika SENUMA,
Mami FURUYA, Hiromasa TAKASHIMA
7th World Congress on Alternatives & Animal Use in the Life Sciences 2009.8.30～9.3（Rome, Italy）
Alternative to Animal Experimentation, 2009; 26, Special Issue: 116
1

Department of Biomaterials, Osaka Dental University; 2Department of Pharmacology, National

Research Institute for Child Health and Development
Evaluation of the embryotoxicity of alloys containing indium with whole-embryo culture
and embryonic stem cell test
Hiromasa TAKASHIMA, Mika SENUMA, Makiko KUWAGATA, Mami FURUYA, Yuka YOSHIDA, Kohichi
KOJIMA, Koichi IMAI1
7th World Congress on Alternatives & Animal Use in the Life Sciences 2009.8.30～9.3（Rome, Italy）
Alternative to Animal Experimentation, 2009; 26, Special Issue: 320
1

68

Department of Biomaterials, Osaka Dental University

研究業績

OECD試験法ガイドライン計画で策定中の「延長一世代生殖毒性試験」について
小野宏

第17回生殖・発生毒性学東京セミナー

2009.10.2（東京）

新生児期の化学物質暴露による生殖器系の発達および老化に及ぼす影響の研究
大向英夫, 太田亮, 宮原敬, 豊泉友康, 丸茂秀樹, 小野

環境ホルモン学会第12回研究発表会

宏2009.12.7～12.8（東京）

同会要旨集, p. 155

細胞毒性学
形質転換試験のバリデーション研究酒井綾子
JaCVAM第2回ワークショップ

2009.4.17（東京）

同会要旨集, pp. 3-4
In vitro 代替試験法の開発の概要―発がん，免疫毒性，催奇形性試験―
田中憲穂
JALAM（日本実験動物医学会）シンポジウム「安全性試験における動物実験代替法―国内外の動向と代替法開発の現状―」2009.5.13（さいたま）同会要旨集, p. 3
Characteristics and performance of a Bhas 42 cell transformation assay for prediction ofchemical carcinogenicity
Ayako SAKAI, Kiyoshi SASAKI, Dai MURAMATSU, Shoko ARAI, Nobuko ENDOU, Sachiko KURODA,
Kumiko HAYASHI, Yeon-mi LIM, Shojiro YAMAZAKI, Makoto UMEDA, Noriho TANAKA
10th Inernational Conference on Environmental Mutagens (ICEM) 2009.8.20～8.25（Firenze, Italy）
同会 Scientific Program and Abstract Book, p. 270
Strategies for high-throughput screening carcinogens based on Bhas 42 celltransformation assay
Kiyoshi SASAKI, Ayako SAKAI, Shin ASADA, Dai MURAMATSU, Shoko ARAI, Shinsuke UDA1, Nobuko
ENDOU, Shojiro YAMAZAKI, Makoto UMEDA, Shinya KURODA1, Noriho TANAKA
Genomics in Cancer Risk Assessment 2009.8.27～8.28（Venice, Italy）
同会Poster Abstracts, p. 2
1

Department of Biophysics and Biochemistry, The University of Tokyo

Bhas 42 cell transformation assay to detect carcinogens using 96-well plates and a robotic
system for high-throughput screening
Kiyoshi SASAKI, Masanori WADA1, Nobuko ENDOU, Dai MURAMATSU, Shoko ARAI, Ayako SAKAI,
Shojiro YAMAZAKI, Makoto UMEDA, Noriho TANAKA
7th World Congress on Alternatives & Animal Use in the Life Sciences 2009.8.30～9.3（Rome, Italy）
Alternative to Animal Experimentation, 2009; 26, Special Issue: 320
1

Institution ABLE
69

秦野研究所年報 Vol. 33. 2010

Bhas 42 細胞形質転換試験のガイドライン化を目指して
佐々木澄志, 村松大, 新井晶子, 遠藤伸子, 黒田幸子, 林

梅田

1

久美子, 酒井綾子, 山崎晶次郎, Lim Yeon-mi,

誠, 和田昌憲 , 田中憲穂

第22回日本動物実験代替法学会総会・学術大会

2009.11.13～11.15（吹田）同会要旨集, p. 46
1

エイブル

Bhas 42 細胞形質転換試験の特性と化学物質の発がん性に関する予測能酒井綾子, 佐々木澄志, 村松
梅田大, 新井晶子, 遠藤伸子, 黒田幸子, 林

久美子, Lim Yeon-mi, 山崎晶次郎,

誠, 田中憲穂

第22回日本動物実験代替法学会総会・学術大会

2009.11.13～11.15（吹田）同会要旨集, p. 123
形質転換 Bhas 42 細胞と導入 v-Ha-ras 遺伝子との関連性について
Lim Yeon-mi, 佐々木澄志, 酒井綾子, 村松
日本環境変異原学会第38回大会

大, 新井晶子, 遠藤伸子, 山崎晶次郎, 田中憲穂

2009.11.26～11.27（静岡）同会プログラム・要旨集, p. 157
Bhas 42 細胞における v-Ha-ras 遺伝子の安定性について
村松 大, 浅田 晋, 佐々木澄志, 酒井綾子, Lim Yeon-mi, 新井晶子, 遠藤伸子, 山崎晶次郎, 梅田 誠, 田中憲穂
日本環境変異原学会第38回大会

2009.11.26～11.27（静岡）同会プログラム・要旨集, p. 157―染色体工学技術を中心とした新産業の創出を目指して―（財）
食品薬品安全センター秦野研究所とのかかわり
田中憲穂「とっとりバイオフロンティア事業」第1回シンポジウム・交流会 鳥取県，鳥取大学，（財）鳥取県産業振興機構 共催 2010.2.27（米子）

遺伝毒性学
The NEDO project on carcinogenicity
Noriho TANAKA
7th World Congress on Alternatives & Animal Use in the Life Sciences 2009.8.30～9.3（Rome, Italy）
Alternative to Animal Experimentation, 2009; 26, Special Issue: 250
gpt delta トランスジェニックラットを用いた遺伝毒性試験の共同研究―1) 肝発癌物質と非発癌物質の識別―
太田

亮, 須井

哉, 白菊敏之1, 赤堀文香2, 中嶋

日本環境変異原学会第38回大会

圓2, 林

宏行3, 増村健一4, 能美健彦42009.11.26～11.27（静岡）同会プログラム・要旨集, p. 103
1

大塚製薬株式会社徳島研究所; 2財団法人食品農医薬品安全評価センター; 3明治製薬株式会社医薬総合研究所; 4国立医薬品食品衛生研究所

70

研究業績

ハイ・スループット微生物遺伝毒性試験法の検討5
須井哉, 川上久美子, 桜井徳子, 奥富弘子, 太田

日本環境変異原学会第38回大会

亮, 能美健彦1

2009.11.26～11.27（静岡）同会プログラム・要旨集, p. 112
1

国立医薬品食品衛生研究所

ヘアレスマウスを用いる皮膚コメットアッセイの検討
豊泉友康, 太田亮, 松本浩孝, 田面喜之, 中川ゆづき, 山影康次

日本環境変異原学会第38回大会

2009.11.26～11.27（静岡）同会プログラム・要旨集, p. 110

環境衛生学
カビと臭気
高橋淳子
NPO法人カビ相談センター第2回講演会

2009.7.10（東京）

同会要旨集
公衆浴場における消毒副生成物の暴露評価と真菌汚染の実態調査について
高橋淳子, 香川（田中）聡子1, 久保田佳子, 大島赴夫, 小島幸一, 泉山信司2, 遠藤卓郎2, 高鳥浩介3, 神野透人1
第9回環境技術学会研究発表大会

2009.9.11（堺）同会予稿集, pp. 143-144
1

国立医薬品食品衛生研究所; 2国立感染症研究所; 3帯広畜産大学

モノクロラミン（塩素代替消毒剤）の皮膚一次刺激性に関する研究
高橋淳子, 久保田佳子, 畔上二郎, 大島赴夫, 小島幸一, 香川（田中）聡子1, 神野透人1, 泉山信司2, 遠藤卓郎2
日本防菌防黴学会第36回年次大会

2009.9.14～9.15（豊中）

同会要旨集, p. 126
1

国立医薬品食品衛生研究所; 2国立感染症研究所

幼児期ラットへのナノ粒子を多く含むディーゼル排気粒子の鼻腔内投与が成長後の情動性，学習能に与える影響
横田俊二, 藤谷雄二1, 平野靖史郎1, 藤巻秀和1
第50回大気環境学会年会

2009.9.16～9.18（横浜）

同会講演要旨集, p. 340
1

独立行政法人国立環境研究所

公衆浴場における消毒副生成物の暴露評価
高橋淳子, 香川（田中）聡子1, 久保田佳子, 大島赴夫, 小島幸一, 泉山信司2, 神野透人1, 遠藤卓郎2
フォーラム2009：衛生薬学・環境トキシコロジー

2009.11.5～11.6（宜野湾）

同会講演要旨集, p. 328
1

国立医薬品食品衛生研究所; 2国立感染症研究所

71

秦野研究所年報 Vol. 33. 2010

食品衛生学
検査機関の信頼性確保のための外部精度管理渡辺卓穂
東京コンファレンス2009 （日本分析化学会，日本分析機器工業会共済）2009.9.2～9.4（千葉）
同会講演要旨集, p. 23

医療機器
医用材料の生物学的安全性の評価
小島幸一
日本材料科学会「医用・生体材料分科会」2010.3.18（東京）薬理学
Locally applied TCP inhibits tumor via possible activation of macrophages
Yukiko NAITO, Tomoko NAGATA, Shigehiro TACHIBANA, Yoshiaki SAITO, Yasuharu HAKAMATSUKA1,
Jinyan CHENG1
9th Asian BioCeramics Symposium (ABC2009)2009.12.8～12.11（名古屋）Archives of BioCeramics Research, 2009; 9: 311-314
1Medical New Business Project, Corporate R&D Center, Olympus Corporation

食品・食品添加物
カノーラ油を摂取させたSHRSPラットのG6PD活性上昇とインスリンとの関係
立花滋博, 福光徹, 沖本麻莉, 永田伴子, 内藤由紀子, 大原直樹, 奥山治美1,2

第36回日本トキシコロジー学会学術年会

2009.7.6～7.8（盛岡）Journal of Toxicological Sciences, 2009; 34(Suppl.): S194
1

金城学院大学薬学部; 2金城学院大学オープンリサーチセンター

F344ラットにおける植物油の長期混餌投与の影響―大豆油，カノーラ油およびパーム油の比較―
立花滋博, 内藤由紀子, 永田伴子, 古谷真美, 関
日本脂質栄養学会第18回大会

剛幸, 大原直樹1,2, 奥山治美1,2

2009.9.4～9.5（東京）Journal of Lipid Nutrition, 2009; 18(2): 197
1

金城学院大学薬学部; 2金城学院大学オープンリサーチセンター

食品機能学
カノーラ油を6週間摂取したSHRSPの腎傷害および酸化ストレスの関与
内藤由紀子, 立花滋博, 沖本麻莉, 永田伴子, 古谷真美, 大原直樹1
日本脂質栄養学会第18回大会

2009.9.4～9.5（東京）Journal of Lipid Nutrition, 2009; 18(2): 196
172

金城学院大学薬学部

研究業績

発生神経毒性学
ラット胎生期バルプロ酸曝露の胎児脳発達への影響
桑形麻樹子, 小川哲郎1, 塩田清二2, 永田伴子
第49回日本先天異常学会学術集会

2009.6.25～6.27（鹿児島）

同会抄録集, p. 74
1

昭和大学医学部アンチエイジング寄付講座; 2昭和大学医学部第一解剖学教室

胎生期バルプロ酸曝露動物における新生児脳評価；胎児脳観察と生後脳観察の比較
桑形麻樹子, 小川哲郎1, 臼見憲司, 熊谷文明, 塩田清二1, 斉藤義明, 永田伴子
第26回日本毒性病理学会学術集会

2010.2.2～2.4（金沢）

同会講演要旨集, p. 100
1昭和大学医学部第一解剖学教室

Valproate-induced abnormal development neurotoxicity: fetal brain observation versus
postnatal brain observation
Makiko KUWAGATA, Tetsuo OGAWA1,2, Seiji SHIODA1, Tomoko NAGATA
49th Annual Meeting, Society of Toxicology 2010.3.7～3.11（Salt Lake City, USA）
Toxicologist, 2010: 36
1

Anatomy I, Showa University, School of Medicine; 2Anti-aging Medicine Funded Research Labs,

Showa University, School of Medicine
Distribution of c-fos-like immunoreactivities in the neonatal rat brain shortly aftermaternal deprivation in the BrdU-induced hyperactivity model
Tetsuo OGAWA1,2, Makiko KUWAGATA, Tomoko NAGATA, Seiji SHIODA2
49th Annual Meeting, Society of Toxicology 2010.3.7～3.11（Salt Lake City, USA）
Toxicologist, 2010: 36
1Anti-aging Medicine Funded Research Labs, Showa University, School of Medicine; 2Anatomy I,

Showa University, School of Medicine

内分泌学
プロラクチンによる副腎皮質ステロイドホルモンの分泌促進作用
田谷一善1, Sukanya JAROENPORN 2, 永岡謙太郎3, 太田
第82回日本内分泌学会学術総会

亮, 渡辺

元1

2009.4.23～4.25（前橋）日本内分泌学会雑誌, 2009; 85(1): 26
1

東京農工大学; 2タイ・チュラロンコン大学; 3東京大学

Behavioral profile in ovariectomized female Hatano high- and low-avoidance rats
Maiko KAWAGUCHI1, Ryo OHTA, Hiroko MAKIHARA1, Gen WATANABE2,3, Kazuyoshi TAYA2,3, Tsutomu
SHIMADA1, Masaki ABURATA1, Nobumasa KATO4, Toshiyuki HIMI1
14th International Congress of Endocrinology 2010.3.26～3.30（京都）
同会抄録集, p. S527
1

Research Institute of Pharmaceutical Science, Musashino University; 2Laboratory of Veterinary73

秦野研究所年報 Vol. 33. 2010

Physiology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University ofAgriculture and Technology; 3Department of Basic Veterinary Science, The United Graduate
School of Veterinary Sciences, Gifu University; 4Department of Psychiatry, School of Medicine,Showa University
Endocrine Mechanisms responsible for different ovarian follicular development during
the estrous cycle between High- and Low-avoidance Hatano Rats
Yasuyuki HORII1,2, Sukanya JAROENPORN3, Sayaka ASAI4, KaiMing WANG2, Ryo OHTA, Mariko SHIROTA5,
Gen WATABABE1,2, Kazuyoshi TAYA1,2
14th International Congress of Endocrinology 2010.3.26～3.30（京都）
同会抄録集, p. S596
1

Department of Basic Veterinary Science, The United Graduate School of Veterinary Sciences,

Gifu University; 2Laboratory of Veterinary Physiology, Department of Veterinary Medicine,
Faculty of Agriculture, Tokyo University of Agriculture and Technology; 3Primate Research
Unit, Department of Biology, Faculty of Science, Chulalongkorn University; 4Department
of Internal Medicine, Miyazaki Medical College, University of Miyazaki; 5Laboratory ofComparative Toxicology, School of Veterinary Medicine, Azabu University

GLP
医薬品・医療機器GLP調査・査察事例報告
山口一喜
JSQA GLP部会第一分科会総会

74

2009.6.18（浜松）研究業績

謝辞 Acknowledgements
論文発表等の要旨を本年報に掲載するにあたり，下記の機関，出版社から，転載の許可を得ました．
記
日本環境化学会（Journal of Environmental Chemistry）

日本環境変異原学会（Genes and Environment）

日本材料科学会（材料の科学と工学）

日本実験動物学会（Experimental Animals）

Elsevier Ltd.

（Food and Chemical Toxicology,
International Journal of Developmental Neuroscience,
Life Sciences,
Mutation Research,
Regulatory Toxicology and Pharmacology）

John Wiley and Sons

（Congenital Anomalies, Journal of
Biomedical Materials Research Part A）

Springer（Cell Biology and Toxicology）

Wolters Kluwer Health （NeuroReport）
なお，下記の機関は要旨の転載に関して承認を求めていません．
日本動物実験代替法学会 （Alternatives to Animal Testing and Experimentation）
Informa Healthcare（Stress）

75